ONS 2020 - 45th Annual Congress of Oncology Nursing Society (Virtual Meeting)
Apr 29 - May 03, 2020 | San AntonioTXUS
LARVOL is not affiliated with 45th Annual Congress of Oncology Nursing Society (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Showing 9 abstracts linked to Trials
Clinical Relevance of Drug–Drug Interactions with Darolutamide
Long-term Treatment Outcome With Niraparib in Patients With Recurrent Ovarian Cancer: Results From the ENGOT-OV16/NOVA Trial
Five Years of Follow-Up From the Phase 3 RESONATE-2 Study and Nursing Experience With Patients Receiving First-Line Ibrutinib for Chronic Lymphocytic Leukemia
Nursing Considerations for the Use of Isatuximab in the Treatment of Multiple Myeloma
Role of the Clinical Oncology Nurse in the Malignant Pleural Mesothelioma-Tumor Treating Fields Patient Journey
Malignant Pleural Mesothelioma and Tumor Treating Fields: Nurses’ Impact on Symptom Management
Encorafenib plus Cetuximab With or Without Binimetinib for BRAF V600E–Mutant Metastatic Colorectal Cancer: Management of Adverse Events from a Randomized, 3-Arm, Phase 3 Study vs. the Choice of Either Irinotecan or FOLFIRI plus Cetuximab (BEACON CRC)
Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
Treatment Considerations for Patients With Advanced Breast Cancer Who Receive Alpelisib After CDK4/6 Inhibitor-Based Therapy